Pandolfi C
Minerva Med. 1986 Jun 30;77(27):1317-9.
Serial serum thyroglobulin determinations and 131I whole body scans are the main diagnostic tools in the follow-up study of patients with treated differentiated thyroid cancer. A thyroglobulin level below 1 ng/ml during suppressive therapy is unsuspicious . In two thirds of patients there is discordance of iodide trapping and thyroglobulin secretion: thyroglobulin assay can't therefore be used as a predictive index of radioiodine uptake.
连续血清甲状腺球蛋白测定和¹³¹I全身扫描是分化型甲状腺癌治疗后患者随访研究中的主要诊断工具。抑制性治疗期间甲状腺球蛋白水平低于1 ng/ml不具可疑性。三分之二的患者存在碘摄取与甲状腺球蛋白分泌不一致的情况：因此甲状腺球蛋白测定不能用作放射性碘摄取的预测指标。
